Gain Therapeutics, Inc. (GANX) vs Outset Medical, Inc. (OM)
A side-by-side comparison of Gain Therapeutics, Inc. and Outset Medical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GANX
Gain Therapeutics, Inc.
$1.67HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
OM
Outset Medical, Inc.
$4.14HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — GANX vs OM
growth of $100 · dividends reinvested · last 6yGANX -84.9% (-27.0%/yr)OM -99.4% (-57.9%/yr)GANX compounded faster over this window
Log scale — wide-divergence pair
GANX OM
GANX vs OM: by the numbers
- •OM is the larger company ($77M vs $71M market cap).
- •Both run net losses; GANX's is the smaller (0.00% vs -63.06% net margin).
Metrics side by side
Valuation
| Metric | GANX | OM |
|---|---|---|
| P/S ratio | N/A | 0.65 |
| P/B ratio | 6.31 | 0.80 |
Profitability
| Metric | GANX | OM |
|---|---|---|
| Gross margin | 0.00% | 41.76% |
| Operating margin | 0.00% | -56.06% |
| Net margin | 0.00% | -63.06% |
| ROE | -178.06% | -77.12% |
| ROIC | -159.24% | -33.27% |
Growth (annualized)
| Metric | GANX | OM |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 8.28% |
| Total return CAGR (5Y) | -25.06% | -64.47% |
Frequently asked
- How have GANX and OM total returns compared?
- Over the past 5 years, GANX delivered -25.06% and OM delivered -64.47% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.